Karolinska Institutet Campus Flemingsberg
Stockholm Life Tech
Making research and innovation infrastructures available
Stockholm Life Tech is a three-year project that started in 2020 with funding from the European Regional Development Fund. Project owner is Region Stockholm, and the project parties are Akademiska Hus, Flemingsberg Science, Karolinska Institutet, Karolinska Institutet Science Park, Karolinska University Hospital, and Stockholm Science City. The purpose of the project is to further develop research and innovation infrastructures as well as making them more available for companies.
This includes opening up the advanced development and production environments in Flemingsberg and Hagastaden for small and medium-sized companies.
Goals of the project:
- To increase growth in small and medium-sized life science companies in the two strong life science environments Flemingsberg and Hagastaden
- Making laboratories and research and innovation infrastructures available to companies in and around the two strong life science environments
- To increase the Stockholm region’s attractiveness with a special focus on life science
The goal is to reach 200 companies with different forms of support, to develop and test generic and scalable methods and models for companies’ ability to use research and innovation infrastructures in Flemingsberg and Hagastaden, and to increase collaboration between different types of research and innovation infrastructures.
Stockholm Life Tech to realize region’s innovative power
Planning and preparation for the Stockholm Life Tech project is well underway. Heading the initiative is Nina Lahti, the respected project manager, who believes that the development of the innovation ecosystem is vital for the future of the region.
Campus Flemingsberg plays key role in fight against Covid-19
Work on a Swedish vaccine for the coronavirus is in full swing at Campus Flemingsberg, although it differs from other vaccines being developed around the world. If successful, the Swedish vaccine could also help combat future pandemics.
He has built up Sweden’s leading gene and cell therapy lab
Pontus Blomberg has guided the development of Vecura in Flemingsberg for more than 20 years. Here, together with his colleagues, he has built up Sweden’s leading gene and cell therapy lab. An area that is set to lead to remedial treatments for everything from certain cancers to Alzheimer’s.
